Novel N-substituted-pyrrolidines as inhibitors of MDM2-p-53 interactions

Details for Australian Patent Application No. 2010305914 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Bartkovits, David Joseph; Chu, Xin-Jie; Liu, Jin-Jun; Ross, Tina Morgan; Zhang, Zhuming

Agent Griffith Hack

Pub. Number AU-A-2010305914

PCT Pub. Number WO2011/045257

Priority 61/345,626 18.05.10 US; 61/251,413 14.10.09 US

Filing date 11 October 2010

Wipo publication date 21 April 2011

International Classifications

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/402 (2006.01) - 1-aryl-substituted, e.g. piretanide

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/045257 Priority application(s): WO2011/045257

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010305917-Package for cushioning food product

2010305911-Process for tertiary mineral oil production using surfactant mixtures